Cancer
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity. The updated lists now include a total of 523 essential
Cancer
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), adding new treatments for cancer, diabetes, and other conditions. The revised lists include 20 new medicines for adults and 15 for children, along with new use indications
Cancer
Researchers have detailed new data in venous thromboembolism, highlighting the risks associated with cancer-related venous thromboembolism (VTE). According to the study, patients with cancer-associated VTE are at increased risk of both recurrent VTE and bleeding, with the magnitude of this variation remaining unclear. The study aimed to compare the 90-day
Cancer
Pediatric hematology oncology providers are interested in learning more about acupuncture as a symptom management tool for their patients with cancer, despite being reluctant to recommend it due to a lack of robust data in the pediatric oncology population. A cross-sectional survey of 78 providers at a US pediatric cancer
Cancer
Researchers from Georgetown University Medical Center have conducted parallel phase II clinical trials to evaluate the efficacy and safety of selinexor, an inhibitor of the nuclear receptor exportin-1 (XPO1/CRM1), in patients with advanced thymoma and thymic carcinoma. The trials, which enrolled 31 patients, demonstrated modest anticancer activity with limited
Cancer
MetLife has announced the launch of a new Cancer Support benefit, designed to provide personalized advice and attention to employees diagnosed with cancer. The benefit, developed in partnership with Private Health Management, aims to offer comprehensive care navigation, expert-led coordination, and patient counseling to help individuals navigate the complexities of
Cancer
Researchers at Indiana University School of Medicine have developed a novel method to transform immunosuppressive cells within tumors into cancer fighters. This groundbreaking approach, published in Science Immunology, has the potential to revolutionize treatments for aggressive cancers such as triple-negative breast cancer, colorectal cancer, and melanoma. By targeting the FOXP3
Cancer
The cancer gene therapy market is experiencing significant growth, driven by the growing demand for painless treatment at lower cost, coupled with increasing aesthetic consciousness among the population, significantly increasing the demand for cancer gene therapy across different parts of the globe. The global market for cancer gene therapy was
Cancer
Akeso's global partner, Summit Therapeutics, has announced updated overall survival (OS) results from the global Phase III HARMONi clinical trial of ivonescimab, a novel PD-1/VEGF bispecific antibody. The results demonstrate a consistent and robust clinical efficacy in both progression-free survival (PFS) and OS across diverse global populations.
Cancer
Sir Chris Hoy, the retired track cyclist and Scotland's most successful Olympian, has launched a fitness partnership with PureGym, the Institute of Cancer Research, and the Royal Marsden NHS Foundation Trust to support men living with late-stage prostate cancer. The partnership offers free, one-year gym memberships to men
Cancer
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), incorporating new treatments for various cancers, diabetes, and other conditions. The revised list features medicines for cystic fibrosis, psoriasis, haemophilia, and other blood-related disorders, as well as
Cancer
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), adding new treatments for cancer, diabetes, and other conditions. The revised lists include 20 new medicines for adults and 15 for children, as well as new use
